Krystal Biotech (KRYS) FCF Margin (2023 - 2026)
Krystal Biotech (KRYS) reported FCF Margin of 59.74% for Q2 2026, up 6.82 percentage points from 52.92% a year earlier but down 3.18 percentage points from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) FCF Margin (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Krystal Biotech's FCF Margin came in at 58.52%, up 6.89 percentage points year-over-year; for FY2025, it was 48.55%, up 7.52 percentage points from FY2024.
- By year, FCF Margin came in at 41.02% in FY2024 (+239.45 pp) and -198.43% in FY2023.
- Five-year quarterly FCF Margin spans a low of -268.90% in Q3 2023 and a high of 70.37% in Q4 2025.
- Year over year, FCF Margin has now increased in each of the last three quarters, with an average year-over-year change of +62.19 percentage points over the last eight quarters.
- The high point for year-over-year FCF Margin in five years was Q3 2024 (a gain of 337.85 percentage points); the low point was Q3 2025 (a drop of 30.14 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 62.92% (Q1 2026), 70.37% (Q4 2025) and 38.81% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Krystal Biotech | 9.98 Bn | 6.75 Bn | 112.79 Mn | 59.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.74% |
| Mar 31, 2026 | 62.92% |
| Dec 31, 2025 | 70.37% |
| Sep 30, 2025 | 38.81% |
| Jun 30, 2025 | 52.92% |
| Mar 31, 2025 | 28.08% |
| Dec 31, 2024 | 57.12% |
| Sep 30, 2024 | 68.95% |
| Jun 30, 2024 | -7.54% |
| Mar 31, 2024 | 32.29% |
| Dec 31, 2023 | -21.54% |
| Sep 30, 2023 | -268.90% |
API Access
Krystal Biotech FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();